Design Therapeutics (DSGN) Times Interest Earned (2020 - 2026)
Design Therapeutics (DSGN) reported Times Interest Earned of -$5.87 for Q1 2026, up 26.93% on a YoY basis from -$4.63 in Q1 2025, and up 29.35% sequentially from -$8.31 in Q4 2025.
Design Therapeutics (DSGN) Times Interest Earned (2020 - 2026) Analysis & Trends
Design Therapeutics (DSGN) has 7 years of Times Interest Earned data on file, last reported at -$5.87 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned rose 26.93% year-over-year to -$5.87; the trailing twelve-month figure through Mar 2026 stood at -$23.47 (down 231.28% YoY), and the FY2025 full-year result was -$0.0, up 53.41% from the prior year.
- Times Interest Earned improved to -$5.87 in Q1 2026, from -$8.31 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$0.0 in Q4 2022 to a low of -$14.66 in Q3 2023.
- A 5-year average of -$6.76 and a median of -$6.82 in 2024 frame the typical range for Times Interest Earned.
- Peak annual rise in Times Interest Earned reached 51.22% in 2024, while the deepest fall reached 46604.93% in 2024.
- Tracing DSGN's Times Interest Earned over 5 years: stood at -$0.0 in 2022, then sank by 636.27% to -$0.01 in 2023, then sank by 46604.93% to -$6.33 in 2024, then slumped by 31.29% to -$8.31 in 2025, then climbed by 29.35% to -$5.87 in 2026.
- Business Quant data shows DSGN's Times Interest Earned at -$5.87 in Q1 2026, -$8.31 in Q4 2025, and -$8.51 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Design Therapeutics | 725.54 Mn | 502.72 Mn | - | -5.87 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.87 |
| Dec 31, 2025 | -8.31 |
| Sep 30, 2025 | -8.51 |
| Jun 30, 2025 | -7.87 |
| Mar 31, 2025 | -8.04 |
| Dec 31, 2024 | -6.33 |
| Sep 30, 2024 | -7.15 |
| Jun 30, 2024 | -6.82 |
| Mar 31, 2024 | -6.56 |
| Dec 31, 2023 | -0.01 |
| Sep 30, 2023 | -14.66 |
| Jun 30, 2023 | -11.27 |
| Mar 31, 2023 | -5.19 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | -4.97 |
| Jun 30, 2022 | -3.24 |
| Mar 31, 2022 | -10.11 |
| Sep 30, 2021 | -2.45 |
| Jun 30, 2021 | -1.64 |
| Mar 31, 2021 | -7.30 |